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Human visceral leishmaniasis, a parasitic disease of major public health importance in
developing countries, is characterized by variable degrees of severity of anemia, but
the mechanisms underlying this change in peripheral blood have not been thoroughly
explored. Here, we used an experimental model of visceral leishmaniasis in C57BL/6
mice to explore the basis of anemia following infection with Leishmania donovani. 28
days post-infection, mice showed bone marrow dyserythropoiesis by myelogram, with
a reduction of TER119+ CD71−/+ erythroblasts. Reduction of medullary erythropoiesis
coincided with loss of CD169high bone marrow stromal macrophages and a reduction
of CXCL12-expressing stromal cells. Although the spleen is a site of extramedullary
erythropoiesis and erythrophagocytosis, splenectomy did not impact the extent of
anemia or affect the repression of medullary hematopoiesis that was observed in infected
mice. In contrast, these changes in bone marrow erythropoiesis were not evident in
B6.Rag2−/−mice, but could be fully reconstituted by adoptive transfer of IFNγ-producing
but not IFNγ-deficient CD4+ T cells, mimicking the expansion of IFNγ-producing CD4+
T cells that occurs during infection in wild type mice. Collectively, these data indicate
that anemia during experimental murine visceral leishmaniasis can be driven by defects
associated with the bone marrow erythropoietic niche, and that this represents a
further example of CD4+ T cell-mediated immunopathology affecting hematopoietic
competence.
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INTRODUCTION
The bone marrow (BM) is the main site of hematopoiesis in adult mammals and occurs within
the cavities of long bones. Hematopoiesis is a complex process through which hematopoietic stem
cells (HSCs) proliferate and differentiate into mature blood cells and is largely restricted to specific
microenvironments or “niches” that are comprised of a variety of non-hematopoietic stromal cells
and secreted factors. The stromal cell-derived chemokine CXCL12 and its receptor CXCR4 are
responsible for the retention of HSCs in the BM. Disruption of the CXCL12-CXCR4 axis, or
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depletion of CXCL12-abundant reticular (CAR) cells, mobilizes
HSCs in the peripheral blood (1). A wide spectrum of diseases
impact on hematopoiesis in general and on erythropoiesis in
particular by altering these niches, including myeloproliferative
neoplasms and infectious diseases (2). For example, Escherichia
coli and Anaplasma phagocytophilum infections in murine
models has been shown to induce CXCL12 down-regulation
in the BM and subsequent HSC mobilization (3, 4). The
development of anemia is often complex and multifactorial,
as evidenced by experimental studies in infectious disease
models and often reflects a balance between erythropoiesis
and erythrocyte clearance. For example, in Trypanosoma brucei
infection, anemia is in part caused by nitric oxide (NO)
production, and pro-inflammatory cytokines, such as IFNγ
and TNF positively correlate with anemia severity (5). In
contrast, direct lysis of RBC is seen during acute malaria
(6). CD169+ BM stromal macrophages are also an essential
component of the niche for erythropoiesis (7) as well as
important regulators of stromal cells within the HSC niche
(8, 9), but less is known about how their function is
impacted during infection, or in relation to the development of
anemia.
Hematological disturbances are a hallmark of human
and canine visceral leishmaniasis (VL) (10, 11), caused by
infection with the protozoan parasites Leishmania donovani
or L. infantum. Differing degrees of cytopenia are associated
with disease stage, and as risk factors for VL-related death
(12, 13). VL often results in pancytopenia (14–16) and may
sometimes be misdiagnosed as another hematological disorder,
such as myelodysplastic syndrome (17). Various mechanisms
have been proposed to underpin the development of VL-
associated pancytopenia, including auto-immune destruction
of erythrocytes, platelets and leukocytes, or BM failure (18).
Anemia has been attributed to aberrant sialoglycosylation of
red blood cells (19), altered recognition of band 3 subsequent
to oxidative stress (20) or enhanced macrophage-mediated
erythrophagocytosis (21).
While the immune response and hematological consequences
of VL have been extensively studied, far less is known about
the regulation of hematopoiesis per se during disease, in
part due to the ethical challenges involved in studying this
in humans. Hematopoiesis has been examined in a hamster
model of VL (22), with the finding that L. donovani infection
induces apoptosis in erythropoietic progenitors in the BM.
However, lack of tools for dissecting the hamster immune and
hematopoietic microenvironment poses challenges in exploiting
this model. Although the mouse model of VL is not lethal, it has
been extensively studied to provide more mechanistic data on
immunity and immunopathology (23, 24). However, this model
has to date been poorly utilized in the study of hematological
dysfunction. Cotterell et al. demonstrated that chronic VL in
BALB/c mice results in an increase of hematopoietic progenitors
in the spleen and the BM (25), and that BM stromal macrophage-
derived cells may become more supportive of myelopoiesis after
infection with L. donovani in vitro, due to increased secretion of
GM-CSF and TNF (26). More recently, alterations in the HSC
compartment have been described that might contribute both
to ongoing VL-associated immunosuppression (27) and to long
term hematopoietic competence (28).
Here, we have focused on exploring the mechanisms
underpinning anemia in C57BL/6 mice infected with
L. donovani. We show that infected mice develop BM
dyserythropoiesis, evidenced both by myelogram and by a
reduction of medullar TER119+ CD71−/+ erythroblasts.
Reduction of medullary erythropoiesis coincided with loss of
CD169high stromal macrophages and a reduction of CXCL12-
expressing stromal cells. We demonstrate, through the use
of immunodeficient B6.Rag2−/− mice and adoptive cell
transfer, that all of these events strictly require the presence
of CD4+ T cells expressing IFNγ. Hence, we propose that
repression of medullary erythropoiesis is added to the catalog
of immunopathological sequelae associated with Leishmania
donovani infection.
MATERIAL AND METHODS
Ethics Statement
All animal care and experimental procedures were performed
under UK Home Office License (Ref # PPL 60/4377) and with
approval from the Animal Welfare and Ethical Review Board of
the Department of Biology, University of York.
Mice
C57BL/6, B6.Rag2−/−, B6.Cxcl12tm2.1Sjm/J mice (Jackson
Laboratories) and B6.hCD2-DsRed mice were bred at the
University of York. IFNγ-KO (B6.129S7-Ifngtm1Ts/J, stock
no. 002287) mice were obtained from the Jackson Laboratory.
All mice were maintained under specific pathogen-free
conditions (FELASA 67M standard). As appropriate, mice were
micro-chipped, randomly allocated to groups and infected
intravenously with 2–3 × 107 L. donovani (LV9) amastigotes
isolated from the spleen of infected B6.Rag2−/− mice. Mice
were splenectomized (Spx) or sham-operated by a commercial
supplier (Charles River UK), and were allowed to recover for 3
weeks before being infected. As required, 6 × 105 sort-purified
splenic CD45+CD4+CD3+CD8−B220−TCRγδ−CD49b− cells
derived from wild type or IFNγ-KO mice were transplanted into
B6.Rag2−/−.CD45.1Cg recipient mice 24 h prior to infection.
Unless stated otherwise, experimental mice were killed by
cervical dislocation 4 weeks after infection.
Blood Analysis
Blood was collected from terminally anesthetized mice by cardiac
puncture in syringes coated with Citrate-dextrose and transferred
into a EDTA-coated Vacutainer R©. Blood analysis was performed
with a Hemavet 950FS (Drew Scientific).
Bone Marrow Myelogram
BM samples were obtained by aspiration biopsy from the
iliac crest using a 24G needle attached to a 5mL disposable
plastic syringe with 10% EDTA and smears were stained with
May–Grünwald Giemsa. Samples were then re-coded for blind
analysis. A differential count of 500 cells was made in BM
smears to calculate: myeloid: erythroid (M:E) ratio, the myeloid
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maturation ratio, the erythroid maturation ratio, myeloid
precursor cells (myeloblasts + promyelocyte + myelocyte),
percentages of myeloid mature cells (metamyelocyte + band
neutrophils + segmented neutrophils), erythroid precursor
cells (CD71+TER119lo proerythroblasts + CD71−/+TER119high
basophil erythroblasts), erythroid mature cells (polychromatic
erythrocyte + orthochromatic erythrocytes; equivalent to
CD71−/+ TER119high), monocytes, macrophages, plasma cells,
and megakaryocytes according to Yang et al. (29). The dysplasic
features were also analyzed in the myeloid and erythroid series
and in megakaryocytes.
Immunohistochemistry
Femurs were isolated and cleaned to remove excessive tissue then
fixed overnight at 4◦C in periodate-lysine-paraformaldehyde
fixative [10mM sodium periodate dissolved in three parts
0.1M lysine-HCl 0.1M Na2HPO4 and one part 20% (w/)
paraformaldehyde] and decalcified for 3 days at 4◦C with
slow agitation in 10% EDTA, 0.1M Tris, pH6.95. Bones were
transferred in 30% sucrose in PBS for a final overnight incubation
at 4◦C. Spleen and bones were embedded in Optimal Cutting
Temperature (OCTTM) compound (Tissue-Tek) in Cryomolds R©
(Tissue-Tek) and snap-frozen on dry ice. Spleen and femoral
5 µm-sections were cut using a CM1900 cryostat (Leica
Microsystems) onto Polysines R© slides (Thermo Fisher). Spleen
section were fixed in ice-cold acetone for 10min on the day of
staining. Sections were blocked in staining buffer [PBS, 0.05%
(w/v) BSA, 5% goat serum] for 1 h at RT. Excess buffer was
removed and slides stained with fluorochrome-labeled TER119,
F4/80, CD71 or isotype controls (eBioscience) in staining buffer
for 1 h at RT or overnight at 4◦C. Slides were washes three
times for 5min in washing buffer (PBS 0.05% (w/v) BSA) and
counterstained with DAPI. Section were mounted in ProLong R©
Gold antifade reagent (Life Technologies) and sealed before
imaging. Confocal images were obtained using LSM780 or
LSM710 systems (Carl Zeiss) and analyzed using Zen software
(Carl Zeiss). Samples were assessed blind to treatment group.
Flow Cytometry
Spleen cells were dissociated using a 70µm cell strainer. Femurs
were cut at both ends to expose the bone cavity and the BM
was flushed with PBS 1% FCS (flow cytometry buffer) using
a 25-gauge needle through a 70µm cell strainer. Single cell
suspensions were washed (5min at 300 g) and red blood cells
were lysed with ACK buffer (5min at RT). Nucleated cells were
subsequently counted using a Vi Cell XR Cell Counter (Beckman
Coulter). Cell suspensions were incubated in FcBlock (mouse
CD16/32 purified antibody, clone 93) prior to staining with
antibodies specific for CD71 (clone R17217), TER119 (clone
TER-119), and CD45 (clone 30-F11) or with F4/80 (clone BM8),
Ly-6G (clone Gr-1), CD115 (clone AFS98), and CD169 (clone
SER-4). For T cell characterization, cells were labeled with in
optimized concentration of flurochrome-labeled CD45, CD4
(clone RM4-5 or GK1.5), CD8 (clone 53-7.7), TCRγδ (clone GL-
3), B220 (CD45R; clone RA3-6B2), CD49d (clone DX-5), and
CD3 (clone 145-2C11) antibodies diluted in 1× PBS 1% FCS and
left at 4◦C for 30min in the dark. Cells were washed and analyzed
on a Cyan flow cytometer (Beckman Coulter).
Statistical Analysis
Data were analyzed using GraphPad Prism 5.0 (Prism Software,
Irvine, CA, USA). When comparing two groups, Student’s t-
test or Mann-Whitney test was used according to the data
distribution. Welch’s correction was applied for the Student’s t-
test in cases of unequal variances between the two groups. For
multiple comparison, one-way ANOVA or Kruskal-Wallis tests
were used according to the data distribution followed by Turkey’s
or Dunn’s multiple comparison tests, respectively. Downstream
analyses were performed blind to treatment group.
RESULTS
C57BL/6 mice were infected with L. donovani amastigotes by
the intravenous route and blood parameters were measured over
time. Data from naïve mice (n = 14) were used to calculate
the reference interval, or normal range, for each parameter
in the complete blood count. Anemia was first evident at
week 4 post-infection (Table 1, Table S1), a time that also
represents the approximate peak of infection in spleen and
bone marrow (28). The mean red blood cell (RBC) count
per µl of blood was 19% lower in infected mice compared
to their naïve counterparts. 70% of infected mice had RBC
counts below the normal range. Similarly, the mean hemoglobin
(Hb) content in the blood of infected mice was decreased
by ∼15% in infected mice and ∼30% of infected mice had
Hb levels below the reference interval. The average volume of
erythrocytes was unchanged, with a mean corpuscular volume
(MCV) of 51 femtoliter (fl) in both groups but 3/13 infected mice
(23%) had developed a macrocytic anemia. Although the overall
hemoglobin concentration was reduced, all individual mice had
mean corpuscular hemoglobin (MCH) values within the normal
range. Blood film examination indicated the presence of aberrant
red cell morphology with aniso-poikilocytosis, polychromasia,
acanthocytes and nucleated red cells (Figure S1). No significant
change in circulating lymphocytes, granulocytes or monocytes
was measured between naïve and infected mice, except for a
single infected mouse that presented with both lymphopenia and
eosinophilia. Thrombocytopenia was evident. These results all
point toward development of a normochromic anemia coupled
with thrombocytopenia as the most common hematological
consequences of L. donovani in C57BL/6 mice.
Compensatory Extra-Medullary
Erythropoiesis Occurs in the Spleen but
Medullary Erythropoiesis Is Repressed
During EVL
Decrease in hematocrit can be caused by reduced numbers of
circulating erythrocytes, by impairment of erythropoiesis or by
peripheral destruction of RBC. Others have previously reported
erythrophagocytosis occurring in the spleen during experimental
VL (21), associated with splenomegaly. However, the spleen is
also well-known as a site with a propensity for extramedullary
Frontiers in Immunology | www.frontiersin.org 3 December 2018 | Volume 9 | Article 2958
Preham et al. T Cell Repression of Erythropoiesis
TABLE 1 | Hematological characteristics of C57BL/6 mice infected for 28 days
with L. donovani.
Naive Infected
WBC (×103/ul) 6.803 ± 0.864 5.758 ± 0.659
NE (×103/ul) 1.671 ± 0.309 1.108 ± 0.128
LY (×103/ul) 4.486 ± 0.455 4.072 ± 0.626
MO (×103/ul) 0.296 ± 0.072 0.230 ± 0.017
EO (×103/ul) 0.259 ± 0.077 0.108 ± 0.058
BA (×103/ul) 0.077 ± 0.026 0.013 ± 0.003
RBC (×106/ul) 8.110 ± 0.143 6.572 ± 0.241***
HB (g/dl) 9.593 ± 0.213 8.169 ± 0.219***
HCT (%) 41.860 ± 0.900 34.020 ± 1.091***
MCV (fl) 51.610 ± 0.577 51.990 ± 1.035
MCH (pg) 11.860 ± 0.227 12.520 ± 0.198*
MCHC (g/dl) 23.040 ± 0.663 24.130 ± 0.509
PLT (×103/ul) 583.000 ± 45.680 281.500 ± 26.39***
MPV (fl) 4.293 ± 0.143 5.354 ± 0.084***
Bold values are significant: *p < 0.05; ***p < 0.0001.
hematopoiesis. We confirmed that splenomegaly was associated
with extra-medullary erythropoiesis (Figure 1), as determined
by an increased frequency (Figures 1C,D) and absolute
number (Figures 1E,F) of CD45−CD71highTER119low pro-
erythroblasts and CD45−CD71high/lowTER119high erythroblasts
(30). CD71+TER119+ cells localized predominantly within the
enlarged red pulp (Figure 1G). Hence, during experimental VL,
splenomegaly provides both an environment in which splenic
clearance of RBCs can occur (21), as well as an environment
conducive to enhanced compensatory erythropoiesis.
To determine how anemia and medullary erythropoiesis
were altered in the presence or absence of a spleen, we
next compared the BM of splenectomized and sham-operated
C57BL/6 mice. Decolouration of the femurs was observed in
the presence and to a lesser extent in the absence of a spleen
(Figure 2A). Likewise, hematocrit as a measure of anemia was
significantly reduced independently of the presence or absence
of a spleen (Figure 2B). We then stained femur sections with
TER119. Nucleated TER119+ cells were clearly reduced in the
BM of infected mice as determined by confocal microscopy
(Figures 2C,D). In contrast to spleen, flow cytometry with CD71
and TER119 indicated that the number of pro-erythroblasts
(CD71+TER119low cells) in BM was similar between naïve and
infected mice (0.32 ± 0.08 vs. 0.28 ± 0.06) whereas the number
of erythroblasts (CD71−/+TER119high cells) in infected mice was
significantly reduced compared to the naïve mice (2.66 ± 0.16
vs. 0.55 ± 0.14; Figures 2E,F). A similar change in erythroblast
number was also observed in mice splenectomized prior to
infection. Prior to day 28 p.i, we observed no significant alteration
in the frequency of BM erythroid precursors (Figure S2).
Taken together with the data reported in Pinto et al. (28),
showing that infection does not affect the absolute number
or frequency of myeloid-erythroid progenitors (MEPs) in bone
marrow, our data suggest that only the final stages of BM
erythropoiesis are impaired in L. donovani-infected mice, and
that this occurs independently of splenomegaly and splenic
function.
Myelogram of BM
To further characterize changes in cellularity of the BM, myeloid
and erythroid cells were analyzed by differential counting
(Table 2). Infected mice had an increased myeloid: erythroid
ratio. Notably, infected mice had an increase in the index of
myeloid maturation compared to naive mice, characterized by
a high frequency of immature myeloid cells with a decrease
in mature myeloid cells. A significant reduction of enucleated
mature erythroid cells was also observed, suggesting disturbance
in the maturation process and consistent with the anemia
observed in blood. In contrast, the frequency of lymphocytes and
macrophages was elevated. Bymorphology, alterations suggestive
of dysplasia in the myeloid and erythroid series, including
maturation asynchrony (nuclei: cytoplasm asynchrony), giant
band cell, megalocyte, fragmented nuclei, binucleated cells
and/or bilobed nuclei and atypical mitosis were all observed in
infected mice. Other findings included emperipolesis and leuco-
erythrophagocytosis (Figure S3).
The Bone Marrow Microenvironment Is
Altered During EVL
To focus more specifically on cellular changes associated with
erythropoiesis, we next examined two major components of the
erythropoietic niche, stromal macrophages and CXCL12-
abundant reticular (CAR) cells. CD169+ BM stromal
macrophages have been reported by others to be important
for supporting the later stages of erythropoiesis (7) and are
identified as Gr-1− CD115− F4/80+ low side scatter (SSClow)
cells (7) with surface expression of CD169 (Figures 3A,B). In
naïve mice, CD169low and CD169high stromal macrophages
could be clearly resolved (Figure 3B). Although the total number
of Gr-1− CD115− F4/80+ SSClow macrophages was similar
between infected and naïve mice (Figure 3C), the ratio of
CD169low: CD169high populations was significantly altered.
In naive mice, CD169low macrophages accounted for 2.77 ±
0.59% of bone marrow cells or ∼5 × 105 cells per femur/tibia,
whereas CD169high stromal macrophages accounted for 1.70 ±
0.29% of total bone marrow cells (∼3.5 × 105 per femur/tibia).
In contrast, in infected mice a clear population of CD169high
stromal cells was not apparent (Figure 3B), and numbers of cells
gated as positive for CD169 expression was reduced to 2.14 ×
105 per femur/tibia (Figure 3D). These data suggest that either
there is a loss of CD169 expression by BM stromal macrophages
as a consequence of the environment created by infection, or
that these cells are lost and replaced in equivalent numbers by
other macrophages that lack CD169. The latter is consistent
with the evidence provided above of enhanced BM myelopoiesis
(Table 2).
CD169+ stromal macrophages are known to interact with
stromal reticular cells that produce CXCL12 (CAR cells) and
that these are composed of mesenchymal stem and progenitor
cells MSPCs (31). Therefore, we examined expression of CXCL12
at both protein and mRNA levels. RT-qPCR analysis of total
BM cells from chronically infected C57BL/6 mice indicated a
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FIGURE 1 | L. donovani infection induces extramedullary erythropoiesis in the spleen. (A,B) Gating strategy for identification of pro-erythroblasts
(CD45−CD71highTER119low) and erythroblasts (CD45−CD71high/lowTER119high) in the spleens of naïve (A) and infected (B) mice. Plots are gated on CD45− live
cells and equal number of live cells. (C) Frequency of pro-erythroblasts in the spleen. (D) Frequency of erythroblasts in the spleen. (E) Absolute number of
pro-erythroblasts per spleen. (F) Absolute number of erythroblasts per spleen. Absolute numbers were calculated by multiplying the cell frequencies by the total
numbers of cells per spleen. (G,H) Representative histology of spleens from control (G) and infected (H) mice. Sections were stained for F4/80 (green), TER119
(white), CD71 (red), and counterstained with DAPI (Blue). F4/80 demarcates the red pulp. All mice were infected for 28 days. Data represent mean ± SEM (unpaired
t-test with Welch’s correction; n = 8 mice per group from two independent experiments).
50% reduction in Cxcl12 mRNA accumulation compared to
naïve mice (Figure 4A). We next used CXCL12 reporter mice
to identify and quantitate CAR cells expressing this chemokine.
By confocal microscopy, there was a clear reduction in the
frequency of cells expressing CXCL12 in infected compared to
naïve mice (Figure 4B). As the extensive ramifications of these
cells made quantification difficult, we performed flow cytometry
to validate these data (Figures 4C,D). In naïve B6.Cxcl12DsRed
mice, the frequency of CAR cells was 0.32 ± 0.02% of total
bone marrow cells, corresponding to 4.84 ± 0.49 × 104 cells
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FIGURE 2 | Medullary erythropoiesis is repressed during experimental visceral leishmaniasis. (A) Femurs isolated from L. donovani-infected mice and age-matched
naïve mice. Representative from 30 mice per group from 10 independent experiment. (B) Hematocrit in naïve and infected mice with and without splenectomy (Spx).
(C,D) Confocal imaging of 5 µm-thick femoral sections from naïve (C) and infected (D) mice stained with DAPI (blue) and TER119 (white). Representative of six mice
per group from two independent experiments. (E) Representative flow cytometry analysis of CD45− BM cells from infected mouse using the erythroid surface markers
CD71 (transferrin receptor) and TER-119. Pro-erythroblasts are CD45− CD71+ TER119low and erythroblasts are CD45− CD71−/+ TER119high. (F) Absolute
number of pro-erythroblasts per femur + tibia in sham operated and Spx mice. Mann Whitney test; n = 14 mice per group from four independent experiments. Data
represent mean ± SEM. All experiments were performed 28 days post-infection.
per femur/tibia. In contrast, the frequency and absolute number
of Ds-Red+ cells were reduced in infected mice (0.11 ± 0.01%
and 1.36 ± 0.20 × 104 cells per femur) (Figures 4E,F). Finally,
to provide a functional confirmation of reduced numbers of
CAR cells, we made use of the property of these cells to
generate adherent fibroblastic colonies (CFU-F) in vitro (32).
We found a reduction in the absolute number of CFU-F in
the BM of infected mice (from 32.6 ± 3.4 CFU-F/1 × 106
BM cells to 11.8 ± 4.5 CFU-F/1 × 106 BM cells in naïve and
infected mice, respectively; Figure 4G). Taken together, these
results suggest that mice infected with L. donovani have reduced
levels of stromal cell support for late-stage erythropoiesis in
the BM.
Bone Marrow Failure Is Linked to the
Adaptive Immune Response
In addition to being a site of hematopoiesis, the BM is also a
site of L. donovani infection (25, 28). To determine whether cell
mediated immunity impacted on medullary erythropoiesis, we
first assessed the number of lymphocytes in the BM of infected
mice. As previously described (28), both CD4+ and CD8+ T cells
were found to accumulate in the BM of infected mice, though
an expansion in the frequency of CD4+ T cells represented the
major change observed (Figure 5A, Figure S4). Accumulation
of T cells was also confirmed by confocal microscopy of femur
sections in B6.hCD2-GFP mice (Figure 5B). In contrast, we
observed no change in the frequency of CD1b+ cells and a
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compensatory decrease in the frequency of B cells. Of note,
similar changes were also observed in mice which had undergone
splenectomy prior to infection, indicating that the spleen plays a
limited role in the accumulation of bone marrow-homing T cells
during infection (Figure 5A).
We next examined erythropoiesis in the BM of B6.Rag2−/−
mice by flow cytometry to determine whether adaptive immunity
played a role in the suppression of medullary erythropoiesis. As
in wild type mice, B6.Rag2−/− mice infected with L. donovani
TABLE 2 | Comparative myelogram of naïve mice and mice infected with
L. donovani for 28 days.
Naive Infected
Myeloid: Erythoid ratio 1.5 (1.3–2.0) 2.1 (1.7–2.8)*
Precursor myeloid: Mature myeloid 0.02 (0.01–0.03) 0.1 (0.04–0.19)*
Nucleated erythroid precursor:
Nucleated erythroid mature
0.02 (0.01–0.03) 0.03 (0.02–0.05)
Precursor myeloid cells (%) 1.0 (0.6–1.1) 4.8 (2.6–6.0)*
Mature myeloid cells (%) 39.7 (35.5–42.5) 34.8 (31.0–38.1)*
Nucleated erythroid precursor cells (%) 0.6 (0.4–0.9) 0.6 (0.2–0.9)
Nucleated erythroid mature cells (%) 26.8 (19.4–30.6) 17.8 (11.8–21.1)*
Lymphocytes (%) 33.0 (26.4–37.4) 41.2 (35.7–47.2)*
Plasma cells (%) 0.4 (0.2–0.6) 0.6 (0.2–1.0)
Monocytes (%) 0.0 (0.0–0.2) 0.3 (0.0–0.7)
Macrophages (%) 0.0 (0.0–0.2) 0.0 (0.0–0.1)
Bold values are significant: *p < 0.05.
had similar numbers of pro-erythroblasts as control uninfected
mice (Figure 5C), despite significantly higher systemic parasite
burden (Figure S5). In contrast, whereas wild type mice had
significantly reduced numbers of erythroblasts, only a modest
and not significant reduction in these cells was observed in
infected B6.Rag2−/− mice (Figure 5D). Similarly, B6.Rag2−/−
mice showed no reduction of Cxcl12 mRNA accumulation after
4 weeks of infection compared to the ∼50% reduction seen in
wild-type mice (Figure 5E). In addition, there was no change
in the expression of CD169high on Gr-1− CD115− F4/80+
SSClow bone marrow macrophages (Figure 5F), and the ratio of
CD169low and CD169high bone marrow stromal macrophages
was similar between the infected and naïve RAG2−/− mice
(Figure 5G).
Finally, we reconstituted B6.Rag2−/− mice by adoptive
transfer of CD4+ T cells prior to infection with L. donovani.
B6.Rag2−/− mice receiving CD4+ T cells displayed anemia
similar to wild type immunocompetent mice, as measured
by both erythrocyte count and hematocrit (Figures 5H,I).
In contrast to these results obtained using adoptively
transferred wild type CD4+ T cells, CD4+ T cells isolated
from IFNγ-deficient B6.Ifnγ−/− mice we unable to induce
anemia (Figures 5H,I), despite equally efficient engraftment
and activation (Figure S6). IFNγ KO T cells are defective
compared to wild type CD4+ T cells in terms of controlling
systemic parasite load (28). Collectively, these data support the
conclusion that both the medullary changes in erythropoiesis
and peripheral anemia seen in experimental VL arise
as a consequence of CD4+ T cell activation and IFNγ
FIGURE 3 | Infection with L. donovani reduces the number of CD169+ stromal macrophages in BM. (A) BM stromal macrophages were identified as Gr-1− CD115−
F4/80+ SSClow cells (9). (B) CD169 expression on BM macrophages of naïve (green) and infected (red) mice. Isotype control (blue) is representative of both naïve and
infected mice. (C) Absolute number of macrophages per leg (1 femur + 1 tibia) according to the gating described in (A,B). (D) Absolute number of CD169low and
CD169high stromal macrophages based on gating in (B). Absolute numbers were calculated from the frequencies multiplied by the total bone marrow cells isolated
from each mouse. Data represent mean ± SEM. All experiments were performed 28 days after infection (unpaired t-test; n = 10 mice per group from two independent
experiments).
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FIGURE 4 | L. donovani infection causes a reduction in CXCL-12-expressing cells in the BM. (A) Cxcl12 mRNA accumulation in BM of naïve and infected mice,
determined by qRT-PCR. (B) Visualization of CXCL12-expressing cells using naïve and infected Cxcl12-DsRed reporter mice. Sectioned were co-stained for laminin
(green) and counterstained with DAPI (blue). (C,D) Flow cytometry analysis of DsRed+ cells in naïve (C) and infected (D) Cxcl12-DsRed reporter mice. Dot plots show
identical number of cells, gated on live single cells. (E) Frequency of DsRed+ cells. (F) Absolute number of DsRed+ cells per femur, calculated from the frequency of
DsRed+ cells in (E) multiplied by the total bone marrow cell count (Mann Whitney test; Data from five naïve mice and nine infected mice from two independent
experiments). (G) Number of CFU-F per million BM cells (Unpaired t-test; n = 7 mice per group from two independent experiments). Data represent mean ± SEM. All
experiments were performed 28 days post-infection with L. donovani.
production, independently of any potential contributions
from splenomegaly.
DISCUSSION
Although evidence abounds that VL causes hematological
alterations in humans, dogs and experimental model, such as
hamsters, very little is known about the underlying mechanisms.
In the present study, we show using an experimental murine
model that CD4+ T cell-dependent adaptive immune responses
to L. donovani underpin anemia through a pathway that involves
repressed BM erythropoiesis consequent on alterations in the
stromal microenvironment of the erythropoietic niche.
We show here that C57BL/6 mice chronically infected with
L. donovani presented with a bi-cytopenia characterized by
normocytic anemia and thrombocytopenia. These findings are
consistent with the hematological data typically reported in
human studies of VL, though indicate that in this strain of mice
at least, there is no accompanying leucopenia. Anemia is often
complex and multifactorial and it is likely that different models
of disease may to a greater or lesser extent exemplify different
underlying mechanisms. For example, multiple mechanisms
have been proposed based on clinical observations for the
profound anemia observed in human VL, including immune-
mediated hemolysis (33) or splenic sequestration (10, 33, 34). In
hamsters infected with L. donovani, anemia associated with lethal
infection was correlated with increased apoptosis of erythroid
progenitors and an increase of IFNγ in the BM and spleen
(21). Our data in murine VL indicates that the spleen may
have counteracting roles, on the one hand permitting enhanced
erythrophagocytosis (21), but on the other serving as a site
of extramedullary compensatory erythropoiesis. Indeed, it is
likely that these events may balance each other, resulting in a
mild anemia in intact mice that is subsequently unaltered by
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FIGURE 5 | IFNγ-producing CD4+ T cells mediate repression of medullary erythropoiesis in experimental VL. (A) Frequency of leucocyte subsets accumulating in the
BM of sham-operated or Spx naïve (open bars) and infected (black bars) mice. Data from one experiment (n = 5) mice per group; Mann-Whitney: not significant (ns).
(B) T cell accumulation in BM visualized using hCD2-DsRed mice. Sectioned were counterstained with DAPI (blue). Femurs representative of 15 mice per group
examined from three independent experiments. (C,D) Absolute numbers of pro-erythroblasts (C) and erythroblasts (D) in the BM of naïve and infected wild type
C57BL/6 or B6.Rag2−/− mice. Absolute numbers were calculated by multiplying frequencies by the total BM cell counts (One-way ANOVA with Turkey’s multiple
(Continued)
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FIGURE 5 | comparison test; n = 10 mice per group from two independent experiments). Data represent mean ± SEM. (E) Cxcl12 mRNA accumulation in total BM
cells from naïve and infected B6.Rag2−/− mice. Intra-sample standardization was performed by normalization to HPRT and inter-sample standardization was done by
normalization to the average expression of the naïve group (n = 8 wild-type mice per group, five naïve and seven infected from one experiment). (F) CD169 expression
on BM macrophages of naïve (green) and infected (red) B6.Rag2−/− mice. Isotype control (blue) is representative of both naïve and infected mice. (G) Absolute
numbers of macrophages per leg (1 femur + 1 tibia), calculated from the frequencies multiplied by the total bone marrow cells isolated from each mouse (n = 3 naïve
and four infected mice from one experiment). (H,I) Anemia, measured as RBC count (H) or hematocrit (I) in B6.Rag2−/− mice receiving adoptive transfer of either
IFNγ-sufficient (WT) or IFNγ-deficient (IFNγKO) CD4+ T cells [n = 4/5 per group; One-way Anova followed by Tukey’s multiple comparisons test: not significant (ns),
*p ≤ 0.05].
splenectomy. The fact that a mild anemia is present in infected
mice independent of the presence or absence of a spleen, with
dysplastic erythroid features, provides a convenient tool to allow
exploration of pathological mechanisms operating within the BM
microenvironment. Although we also observe thrombocytopenia
in L. donovani-infected mice, the mechanisms regulating this
process appear distinct from that controlling erythropoiesis and
will be reported elsewhere.
Our analysis of the BM microenvironment that supports
erythropoiesis has for the first time demonstrated that anemia
in murine models of VL represents an aspect of CD4+ T cell
mediated immunopathology. BM resident stromal macrophages,
identified by the expression of the sialoadhesin CD169 (35),
were reduced in number in infected mice. CD169+ stromal
macrophages have been shown to be essential for stress
erythropoiesis e.g., following chemically-induced anemia, but
their depletion causes minimal disruption of physiological
erythropoiesis. In these studies, there was no correlation between
overt anemia and a reduction of erythroid progenitors in the BM
(7). These data are in line with our observations, since in our
model of EVL, chronic infection results only in a mild anemia
despite a dramatic reduction of erythroid progenitors in the bone
marrow as observed in myelogram and flow cytometry analysis.
We have previously shown that L. donovani amastigotes readily
parasitize CD169+ BM stromal macrophages during chronic
infection and that infection of these cells directly supports an
increase in their capacity to support myelopoiesis (26). Our
current data extends these observations by indicating that the
reduction of the number of CD169+ stromal macrophages is not
a direct consequence of parasitism, as infected B6.Rag2−/− mice
have significantly increased parasite loads in the BM, yet show no
changes in stromal macrophage number. Rather, our data suggest
that loss of stromal macrophages is a further consequence of T
cell dependent immune responses.
While CD169+ stromal macrophages were reduced in
number, the total number of BM macrophages remained stable
or increased during infection. It is unclear if loss of CD169+
stromal macrophages represents depletion or conversion to a
different phenotype, for which specific lineage tracking studies
would be required. STING-mediated activation of BM CD169+
macrophages has been shown to be essential to type I IFN
production by plasmacytoid dendritic in a malaria mouse
model (36), indicating that these cells are directly sensitive to
infections. Similarly, dexamethasone treatment induces CD169
expression on the surface of human macrophages, promoting
in the same time their erythropoiesis-supporting function (37).
Hence, a stromal “CD169” phenotype can be acquired in
differentiated macrophages and is responsive to inflammatory
signals. Interestingly, dexamethasone is also an inhibitor of
iNOS (38), thus suggesting a role for NO in EVL-induced
anemia. Previously, CD169+ macrophages have been shown to
be depleted by G-CSF administration (39). We have observed
a consistent upregulation of circulating G-CSF in infected mice
(data not shown) but to date our attempts to convincingly
neutralize G-CSF in vivo have been unsuccessful. Hence, direct
evidence is still needed to support a role for G-CSF inVL-induced
anemia.
In hamsters and mice, infection with L. donovani causes
an increase of erythroid burst forming units (BFU-E) from
the bone marrow in colony formation assays (22, 25). These
represent very early progenitors of erythroid cells, prior to the
pro-erythroblast stage. In the current study, we show by flow
cytometry that only later stages of erythroid differentiation, at
or after the pro-erythroblast stage, are affected by infection.
This is also reflected in differential counts of bone marrow
cells, showing that nucleated mature erythroid cells were
reduced in infected mice. Furthermore, conditional depletion
of CD169+ cells in a mouse model did not alter the BFU-
E content in the BM of mice (7). These data are collectively
consistent with macrophage-dependent erythroblastic islands
functioning to support erythropoiesis from the erythroblast stage
onwards.
We also report that CXCL12-producingmesenchymal stromal
cells are affected during VL. Infection led to a reduction of Cxcl12
mRNA accumulation in the bone marrow, correlating with a
reduction in the number of CXCL12-expressing cells. The main
mechanism of G-CSF-induced down-regulation of CXCL12 is
protease-dependent (40) but a more complex model including
transcriptional regulation has also been reported. While down-
regulation of CXCL12 is a potentially due to up-regulation of G-
CSF, CD169macrophages are also responsible for the retention of
CAR cells in the bone marrow. It is likely that these mechanisms
together factor into the loss of stromal support in the BM. In
the case of E coli. infection, heightened levels of G-CSF led to a
reduction in CXCL12 expression in the BM via Toll-like receptor
and NOD1/2 signaling (3). This study did not however directly
enumerate CXCL12-producing cells in BM, our observations
here being the first reported instance of loss of these cells during
infectious disease.
In summary, we have shown that IFNγ-producing CD4+ T
cells contribute to anemia in a model of VL, via a mechanism
that involves loss of both macrophages and mesenchymal
stromal elements from the BM erythropoietic niche leading to
dyserythropoiesis. Whether these effects are the result of direct
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IFNγ signaling on CD169+ macrophages and/or mesenchymal
stromal cells, whether they reflect indirect effects of IFNγ on
third party cells or whether they are the consequence of induced
expression of one of the many IFN-responsive genes remains
to be determined. We have also recently shown that CD4+
T cells producing both IFNγ and TNF accumulate in large
numbers in the BM of infected mice, via a mechanism requiring
CD4+ T cell-intrinsic TNF receptor signaling. These cells drive
functional exhaustion within the long-term HSC compartment
(28). Collectively, therefore, a picture emerges whereby CD4+ T
cells play a pathogenic role in the BM that leads to BM failure
with both short and long-term consequences for hematological
health. These data provide an imperative for similar studies in
humans, to determine whether CD4+ T cells likewise have a
causative role in the hematological changes associated with VL
or indeed other infections where BM accumulation of activated
effector T cells occurs.
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